The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
Abstract Background To explore the expression pattern and role of the novel long non-coding RNA LATS2 antisense transcript 1 (LATS2-AS1-001) in gastric cancer (GC). Methods qRT-PCR was applied to evaluate LATS2-AS1-001 expression and correlation with LATS2 in GC. In vitro experiments were performed...
Main Authors: | Dan Sun, Ying Wang, Huan Wang, Yan Xin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-020-01285-w |
Similar Items
-
RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
by: Yi Pan, et al.
Published: (2018-07-01) -
Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
by: Seong Hwi Hong, et al.
Published: (2023-04-01) -
EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment
by: Yatao Yin, et al.
Published: (2017-11-01) -
Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer
by: Li-cong Ma, et al.
Published: (2020-05-01) -
NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling
by: Lei Yin, et al.
Published: (2019-08-01)